Characteristics of the 23 cases of incident cancer in patients with previous cancer
| Patient number | Age (years) | Gender | IBD | Site of previous cancer | Time between previous cancer and entry into the study period (years) | Site of new or recurrent cancer | New (N) or recurrent (R) cancer | Immunosuppressants at the time of entry | Immunosuppressants at the time of diagnosis of cancer |
|---|---|---|---|---|---|---|---|---|---|
| Patients exposed to any immunosuppressant at entry into the study period | |||||||||
| 1 | 67 | M | UC | Colon | 2.2 | Prostate | N | AZA | AZA |
| 2 | 44 | F | CD | Uterine cervix | 1.7 | Rectum | N | AZA | AZA |
| 3 | 59 | M | CD | Kidney | 2.3 | Prostate | N | AZA | AZA |
| 4 | 50 | F | CD | Breast | 0.2 | Skin (BSC) | N | AZA | AZA |
| 5 | 55 | F | UC | Skin (BSC) | 1.3 | Skin (SCC) | N | AZA | AZA |
| 6 | 54 | F | CD | Meningioma | 3.9 | Meningioma | R | AZA | AZA |
| 7 | 56 | M | CD | Skin (BSC) | Skin (SCC) | N | AZA | AZA | |
| Patients receiving no immunosuppressant at entry into the study period | |||||||||
| 8 | 75 | F | CD | Breast | 9.8 | Colon | N | – | – |
| 9 | 67 | M | UC | Lymph nodes (NHL) | 11.4 | Lymph nodes (NHL) | R | – | – |
| 10 | 57 | F | CD | Breast | 8.4 | Breast | R | – | – |
| 11 | 71 | M | IBDU | Rectum | 7.2 | Skin (BSC) | N | – | – |
| 12 | 53 | M | UC | Menaloma | 17.1 | Lung | N | – | – |
| 13 | 57 | F | CD | Small bowel | 21.7 | Small bowel | R | – | – |
| 14 | 78 | M | UC | Rectum | 0.4 | Lung | N | – | – |
| 15 | 48 | F | UC | Colon | 0.8 | Breast | N | – | – |
| 16 | 74 | M | UC | Prostate | 3.1 | Prostate | R | – | – |
| 17 | 57 | F | CD | Kidney | 4.5 | Hodgkin disease | N | – | – |
| 18 | 68 | F | UC | Breast | 11.9 | Kidney | N | – | – |
| 19 | 72 | M | CD | Prostate | 3.8 | Colon | N | – | – |
| 20 | 48 | M | CD | Kidney | 2.0 | Kidney | R | – | – |
| 21 | 60 | M | UC | Melanoma | 0.2 | Melanoma | N | – | – |
| 22 | 64 | M | CD | CLL | 0.7 | Pancreas | N | – | – |
| 23 | 55 | M | CD | Kidney | 0.1 | Rectum | N | – | – |
BSC, basal cell carcinoma; CD, Crohn's disease; CLL, chronic lymphocytic leukemia; F, female; IBDU, IBD unclassified; M, male; NHL, non-Hodgkin lymphoma; SCC, squamous cell carcinoma; UC, ulcerative colitis.